Article
Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors
23 Nov 2018
Abstract excerpt
BACKGROUND: Reduced activity of proprotein convertase subtilisin/kexin type 9 (PCSK9) has been associated with decreased short-term death in patients with septic shock. Whether PCSK9 genotype influences long-term outcomes in sepsis survivors is unknown. METHODS: We evaluated the impact of PCSK9 loss-of-function (LOF) genotype on both 1-year mortality and infection-related readmission (IRR) after an index sepsis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
